389 related articles for article (PubMed ID: 24551591)
21. Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.
Gharbaran R
Tumour Biol; 2016 Sep; 37(9):11573-11588. PubMed ID: 27317256
[TBL] [Abstract][Full Text] [Related]
22. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
De Pasquale V; Pavone LM
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
[TBL] [Abstract][Full Text] [Related]
23. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
Wang A; Miralem T; Templeton DM
Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
[TBL] [Abstract][Full Text] [Related]
24. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance.
Siegel G; Malmsten M; Ermilov E
Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475
[TBL] [Abstract][Full Text] [Related]
25. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor.
Deepa SS; Yamada S; Zako M; Goldberger O; Sugahara K
J Biol Chem; 2004 Sep; 279(36):37368-76. PubMed ID: 15226297
[TBL] [Abstract][Full Text] [Related]
26. The syndecans, tuners of transmembrane signaling.
Zimmermann P; David G
FASEB J; 1999; 13 Suppl():S91-S100. PubMed ID: 10352150
[TBL] [Abstract][Full Text] [Related]
27. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
28. Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer.
Hassan N; Greve B; Espinoza-Sánchez NA; Götte M
Cell Signal; 2021 Jan; 77():109822. PubMed ID: 33152440
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
Mundhenke C; Meyer K; Drew S; Friedl A
Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
[TBL] [Abstract][Full Text] [Related]
30. Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
Depau L; Brunetti J; Falciani C; Mandarini E; Riolo G; Zanchi M; Karousou E; Passi A; Pini A; Bracci L
J Med Chem; 2020 Dec; 63(24):15997-16011. PubMed ID: 33284606
[TBL] [Abstract][Full Text] [Related]
31. Heparan sulfate proteoglycans in glomerular inflammation.
Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
[TBL] [Abstract][Full Text] [Related]
32. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
O'Callaghan P; Zhang X; Li JP
J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.
van der Voort R; Keehnen RM; Beuling EA; Spaargaren M; Pals ST
J Exp Med; 2000 Oct; 192(8):1115-24. PubMed ID: 11034601
[TBL] [Abstract][Full Text] [Related]
34. Syndecans reside in sphingomyelin-enriched low-density fractions of the plasma membrane isolated from a parathyroid cell line.
Podyma-Inoue KA; Hara-Yokoyama M; Shinomura T; Kimura T; Yanagishita M
PLoS One; 2012; 7(3):e32351. PubMed ID: 22396758
[TBL] [Abstract][Full Text] [Related]
35. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
[TBL] [Abstract][Full Text] [Related]
36. The role of heparins and nano-heparins as therapeutic tool in breast cancer.
Afratis NA; Karamanou K; Piperigkou Z; Vynios DH; Theocharis AD
Glycoconj J; 2017 Jun; 34(3):299-307. PubMed ID: 27778131
[TBL] [Abstract][Full Text] [Related]
37. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
38. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
[TBL] [Abstract][Full Text] [Related]
39. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
40. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.
Manon-Jensen T; Multhaupt HA; Couchman JR
FEBS J; 2013 May; 280(10):2320-31. PubMed ID: 23384311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
